Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery

NCT02509312 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Analgesia, Obstetrical
Postpartum Hemorrhage
Opioid Use
Nonsteroidals (NSAIDs)Toxicity
Coagulation Defect; Postpartum
Postoperative Pain
Ketorolac Adverse Reaction
Blood Loss, Postoperative

Interventions

DRUG: Ketorolac
DRUG: Placebo

Sponsor

University Hospitals Cleveland Medical Center